Drug Maker Tells Federal Circuit Ruling Invalidating Velcade Patent Was Error

(February 15, 2017, 3:20 PM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on Feb. 6 heard oral arguments in a dispute over the cancer-fighting prodrug Velcade, following findings in 2015 by a Delaware federal judge that the patent covering the pharmaceutical composition is invalid (Millennium Pharmaceuticals Inc. v. Sandoz Inc., et al., Nos. 2015-2066, 2016-1008, -1009, -1010, -1109, -1110, -1283, Fed. Cir.)....